Drug Information
Drug General Information | |||||
---|---|---|---|---|---|
Drug ID |
D0L1NS
|
||||
Former ID |
DNC012471
|
||||
Drug Name |
2-(4-Benzyl-piperazin-1-yl)-benzothiazole
|
||||
Drug Type |
Small molecular drug
|
||||
Indication | Discovery agent | Investigative | [533917] | ||
Structure |
Download2D MOL |
||||
Formula |
C18H19N3S
|
||||
Canonical SMILES |
C1CN(CCN1CC2=CC=CC=C2)C3=NC4=CC=CC=C4S3
|
||||
InChI |
1S/C18H19N3S/c1-2-6-15(7-3-1)14-20-10-12-21(13-11-20)18-19-16-8-4-5-9-17(16)22-18/h1-9H,10-14H2
|
||||
InChIKey |
SNRZSONRAFJJSB-UHFFFAOYSA-N
|
||||
PubChem Compound ID | |||||
Target and Pathway | |||||
Target(s) | 5-hydroxy-tryptamine 3B receptor | Target Info | Inhibitor | [533917] | |
5-hydroxytryptamine receptor 3A | Target Info | Inhibitor | [533917] | ||
KEGG Pathway | Serotonergic synapsehsa04726:Serotonergic synapse | ||||
NetPath Pathway | IL2 Signaling Pathway | ||||
References |
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.